Author(s): Filho, Marcos Antonio Bonacorso Manhanelli ; Duarte Júnior, Eliud Garcia ; Mariuba, Jamil Victor de Oliveira ; Linardi, Fábio ; Costa, José Augusto ; Gali Filho, Julio Cesar ; Yoshida, Winston Bonetti [UNESP] ; Filho, Julio Cesar Gali
Date: 2021
Persistent ID: http://hdl.handle.net/11449/208264
Origin: Oasisbr
Subject(s): Arterial thrombosis; COVID-19; Heparin; Limb ischemia; Thromboembolism
Made available in DSpace on 2021-06-25T11:09:19Z (GMT). No. of bitstreams: 0 Previous issue date: 2020-01-01. Added 1 bitstream(s) on 2021-07-15T15:24:09Z : No. of bitstreams: 1 S1677-54492020000100623.pdf: 1228997 bytes, checksum: be7f06ab532f9a1e769cc59eb2a3672e (MD5)
The current coronavirus pandemic has already taken a great toll globally, causing massive morbidity and mortality. One of its severe forms is a thrombophilic state that can damage several systems. This article reports the case of 60-year-old female patient who presented with mild flu symptoms, which turned out to be a SARS-CoV2 infection, and ended up developing arterial thrombosis with limb ischemia in a private care hospital in Sorocaba, São Paulo, Brazil. Considering this progression, we decided to intervene with low molecular weight heparin and Alprostadil, achieving a good clinical outcome. Our description aims to identify key points and clinical signs that offer evidence of the therapeutic window and a treatment option for coagulatory presentations of COVID-19.
Pontifícia Universidade Católica de São Paulo – PUC-SP
Conjunto Hospitalar de Sorocaba
Hospital Santa Mônica Cirurgia Vascular e Endovascular
Universidade Vila Velha – UVV
Universidade Estadual Paulista “Júlio de Mesquita Filho” – UNESP
JJMED
Universidade Estadual Paulista “Júlio de Mesquita Filho” – UNESP
